Tissue repair peptides

BPC-157 Lyophilised Peptide

BPC-157 is a synthetic 15-amino-acid peptide whose sequence was reported as a partial sequence of a protein found in human gastric juice. It is classed as an investigational research peptide and has been studied mainly in rodent injury and healing models and in cell culture. BPC-157 is supplied as a lyophilised (freeze-dried) powder in a sealed vial, in 10 mg and 40 mg sizes, priced RM 150–375. No certificate of analysis has been published for the batch on sale yet, so no purity figure is claimed on this page. Ships within 2 working days of payment. Sold for laboratory research use only, not for human or veterinary use.

Research use only. Sold for laboratory research only. Not for human or veterinary use, not for consumption, and not a medicine, food or cosmetic.

Choose a size
  • Ships within 2 working days of payment.
  • Free shipping across Malaysia.
  • Pay by FPX online banking.

Certificates of analysis

No certificate of analysis has been published for the batch on sale yet, so this page makes no purity claim. Each certificate will name the testing laboratory, the batch, the test date and the method.

How to read a certificate of analysis

BPC-157 specifications

BPC-157 specifications
Also known asBody Protection Compound-157, PL 14736, Bepecin, PL-10
FormLyophilised (freeze-dried) powder in a sealed vial
Sizes10 mg · 40 mg
CAS number137525-51-0
Molecular formulaC62H98N16O22
Molecular weight1,419.5 g/mol
SequenceGEPPPGKPADDAGLV
PubChemCID 9941957
Storage (sealed)-20 °C (supplier listing and insert: stable for at least 4 years as a solid)

What research says about BPC-157

BPC-157 is a synthetic 15-amino-acid peptide whose sequence was reported as a partial sequence of a protein found in human gastric juice. It is classed as an investigational research peptide and has been studied mainly in rodent injury and healing models and in cell culture.

In cell and rodent studies BPC-157 has been associated with increased VEGFR2 expression and activation of a VEGFR2-Akt-eNOS pathway in endothelial cells, and with changes in tendon fibroblast migration, survival and growth hormone receptor expression.

Investigational and not an approved medicine; a 2025 narrative review found only three small human pilot studies and described BPC-157 as investigational.

Cited studies

  1. BPC 157 accelerated outgrowth of rat tendon explants and increased migration and survival under H2O2 stress of cultured tendon fibroblasts, without a direct effect on proliferation.

    The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.. J Appl Physiol (1985), 2011. doi:10.1152/japplphysiol.00945.2010 · PubMed 21030672

  2. BPC 157 increased vessel density in chick chorioallantoic membrane and tube-formation assays, and increased VEGFR2 expression and VEGFR2-Akt-eNOS signalling in human endothelial cells.

    Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.. J Mol Med (Berl), 2017. doi:10.1007/s00109-016-1488-y · PubMed 27847966

  3. cDNA microarray analysis showed growth hormone receptor among the most up-regulated genes in BPC 157-treated rat tendon fibroblasts, with dose- and time-dependent increases in mRNA and protein.

    Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts.. Molecules, 2014. doi:10.3390/molecules191119066 · PubMed 25415472

  4. The review summarised broad preclinical data, identified only three human pilot studies, and concluded that BPC-157 should be considered investigational pending well-designed clinical trials.

    Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.. Curr Rev Musculoskelet Med, 2025. doi:10.1007/s12178-025-09990-7 · PubMed 40789979

Handling and storage

Sealed vial
-20 °C (supplier listing and insert: stable for at least 4 years as a solid)

Shipping, returns and payment

Dispatch. Ships within 2 working days of payment.

Shipping. Free shipping across Malaysia. Peninsular Malaysia 1–4 working days; Sabah, Sarawak and Labuan 3–7 working days.

Returns. No change-of-mind returns; a wrong or damaged item is replaced or refunded. Nothing here affects your rights under the Consumer Protection Act 1999.

Payment. FPX online banking.

Questions

Is there a certificate of analysis for BPC-157?

Not yet for the batch on sale. When one is published it appears in the certificates table on this page with the laboratory, batch, test date, method and result. See how to read a certificate of analysis.

How is BPC-157 stored?

Sealed: -20 °C (supplier listing and insert: stable for at least 4 years as a solid). These are supplier figures, cited in the handling section.

More about BPC-157

  • Research summary

    BPC-157: what the published research reports

    BPC-157 is a synthetic 15-amino-acid peptide studied mainly in cell culture and rodent models of tissue injury. A 2025 review found only three small human pilot studies and called it investigational.

  • Comparison

    BPC-157 vs TB-500: how they differ

    BPC-157 is a defined 15-residue synthetic peptide. TB-500 is a supplier name: the biology is published for full-length thymosin beta-4, while one analysed TB-500 product was a seven-residue fragment.